Indiana Administrative Code
Title 410 - INDIANA DEPARTMENT OF HEALTH
Article 1 - COMMUNICABLE DISEASE CONTROL
Rule 2.5 - Disease Reporting and Control
Section 2.5-109 - Human immunodeficiency virus infection/disease; specific control measures

Universal Citation: 410 IN Admin Code 2.5-109

Current through March 20, 2024

Authority: IC 16-19-3-4; IC 16-41-2-1

Affected: IC 16-41

Sec. 109.

The specific control measures for HIV are as follows:

(1) An investigation by a disease intervention specialist shall:

(A) be performed within seventy-two (72) hours; and

(B) include partner services.

Persons who are tested anonymously at counseling and testing sites cannot be reported using personal identifiers. Rather, they are to be reported using a numeric identifier code. Age, race, sex, risk factors, and county of residence shall also be reported. HIV infected persons are required to warn contacts of their disease status and the need to seek health care, such as counseling and testing. All identified contacts should receive counseling and be offered serologic testing. Until their status with regard to infection has been determined, contacts shall refrain from sexual activities involving the exchange of body fluids. All contacts shall not share needles and syringes with other persons without first notifying the other persons of their disease status.

(2) Standard precautions shall be used in hospitalized patients. Universal precautions shall be used for all other medical settings. Infected persons shall not:

(A) engage in sexual activities involving exchange of body fluids without first informing their partner of their disease status;

(B) share needles or syringes with other persons without first notifying the other persons of their disease status; or

(C) donate blood, plasma, organs for transplantation, or semen for artificial insemination.

(3) Concurrent disinfection is required for equipment and articles contaminated by blood or other potentially infectious material.

(4) Quarantine is not required.

(5) An investigation of:

(A) newly diagnosed cases;

(B) HIV positive women; and

(C) perinatally exposed infants; will be performed by HIV surveillance and disease intervention specialist staff members, who will obtain information epidemiologically necessary to protect the life of named parties.

(6) The Centers for Disease Control and Prevention and the Council of State and Territorial Epidemiologists set the standard clinical and laboratory case definition.

Disclaimer: These regulations may not be the most recent version. Indiana may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.